Skip to main content
. 2015 Apr 24;67(5):708–717. doi: 10.1002/acr.22492

Figure 2.

Figure 2

All‐cause health care costs in moderate‐to‐severe PsO+PsA patients and matched controls during the 12‐month study period (univariate and multivariate analyses). Adjusted mean costs were estimated from 2‐part regression models adjusting for age, sex, geographic region, index year, insurance type, and modified Charlson Comorbidity Index calculated based on non–PsO/PsA‐related comorbidities. All P < 0.05 for the comparison of unadjusted and adjusted mean costs between PsO+PsA patients and controls. All costs were adjusted to 2012 US dollars using the medical care component of the consumer price index. PsO = psoriasis; PsA = psoriatic arthritis.